首页> 美国卫生研究院文献>World Journal of Clinical Oncology >Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research
【2h】

Symptom management during and after treatment with concurrent chemoradiotherapy for oropharyngeal cancer: A review of the literature and areas for future research

机译:同期化放疗治疗口咽癌期间和之后的症状管理:文献综述和未来研究领域

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with locally advanced oropharyngeal cancer are at risk for poor outcomes due to the multi-modal nature of treatment and the potential for treatment-related toxicity. Although treatment with concurrent chemotherapy and radiotherapy has drastically reduced the need for a debilitating and disfiguring surgery, treatment related toxicities are often difficult to control. Acute toxicities include mucositis, skin desquamation, depression, cachexia, fatigue and nausea and vomiting. Failure to control these symptoms can adversely affect the patient’s ability to complete their treatment regimen. Although there are many promising new treatments in the area of symptom management for this patient population, a review of the literature reflects the need for more research.
机译:由于治疗的多模式性质和与治疗相关的毒性的潜力,患有局部晚期口咽癌的患者处于不良预后的风险中。尽管同时进行化学疗法和放射疗法的治疗已大大减少了使人衰弱和毁容性手术的需要,但与治疗有关的毒性往往难以控制。急性毒性包括粘膜炎,皮肤脱屑,抑郁,恶病质,疲劳,恶心和呕吐。无法控制这些症状会严重影响患者完成治疗方案的能力。尽管针对该患者人群在症状管理领域有许多有希望的新疗法,但对文献的回顾反映出需要进行更多研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号